dna
vaccin
new
vaccin
bacteri
plasmid
antigen
gene
vector
typic
gene
express
host
cell
promot
regul
express
antigen
target
induc
host
immun
respons
dna
vaccin
develop
base
advantag
compar
convent
vaccin
abil
induc
cellular
immun
respons
instead
humor
immun
respons
express
antigen
could
design
extracellular
protein
detect
major
histocomp
complex
mhc
class
ii
intracellular
protein
recogn
mhc
class
dna
plasmid
also
stabl
room
temperatur
facilit
product
distribut
dna
vaccin
product
directli
use
pathogen
organ
safer
product
system
concern
dna
vaccin
includ
potenti
genom
integr
autoimmun
respons
howev
extens
research
found
risk
integr
limit
significantli
lower
natur
mutat
rate
clinic
trial
also
show
mild
side
effect
dna
vaccin
although
promis
dna
vaccin
need
superior
deliv
system
activ
potent
immun
system
dna
vaccin
requir
larg
dose
effect
induc
immun
system
respons
least
dna
vaccin
need
induc
immun
respons
although
nake
dna
demonstr
efficaci
sever
deliveri
strategi
studi
increas
dna
vaccin
effici
chemic
deliveri
system
use
micro
particl
nanoparticl
success
increas
dna
vaccin
deliveri
anoth
potenti
deliveri
system
improv
dna
vaccin
deliveri
use
live
bacteri
vector
carrier
sinc
develop
late
idea
use
live
bacteria
dna
carrier
grow
rapidli
techniqu
also
known
bactofect
live
bacteria
directli
use
transfer
dna
target
cell
tissu
organ
bactofect
wide
use
field
drug
develop
research
cancer
treatment
infect
inflamm
diseas
metabol
diseas
dna
vaccin
carrier
nativ
recombin
bacteria
use
live
bacteri
vector
deliv
dna
insid
host
cell
also
induc
potent
immun
respons
due
immunogen
featur
review
overview
live
bacteri
vector
dna
vaccin
carrier
futur
prospect
field
provid
dna
vaccin
essenti
includ
two
main
part
mammalian
express
cassett
bacteri
backbon
mammalian
express
cassett
consist
eukaryot
promot
gene
express
untransl
region
includ
intron
polyadenil
sequenc
polya
figur
bacteri
backbon
consist
bacteri
origin
replic
ori
antibiot
resist
gene
select
marker
figur
ideal
multipl
clone
site
mc
use
insert
target
gene
locat
mammalian
express
cassett
bacteri
backbon
mammalian
express
cassett
optim
antigen
gene
highli
express
effect
gener
immun
respons
bacteri
backbon
also
optim
high
yield
dna
plasmid
produc
ferment
product
process
newest
dna
vaccin
version
combin
compon
eukaryot
express
cassett
minim
bacteri
backbon
compon
sinc
reduc
antigen
express
level
escherichia
coli
ori
found
instanc
oriv
puc
vector
still
promin
choic
bacteri
origin
replic
high
copi
number
copi
per
bacteri
cell
oriv
use
earli
gener
dna
vaccin
latest
gener
dna
vaccin
suggest
oriv
still
consid
ideal
ori
dna
vaccin
select
marker
requir
mainten
plasmid
insid
cell
cell
contain
plasmid
appropri
select
marker
surviv
select
condit
dna
plasmid
base
antibiot
resist
gene
select
marker
howev
use
antibiot
resist
gene
result
health
concern
express
spread
resist
gene
effect
microbiota
host
system
thu
european
medicin
agenc
mea
london
uk
recommend
nonantibiot
resist
gene
select
marker
antibiot
resist
gene
replac
marker
select
base
auxotroph
strain
toxinantitoxin
system
operatorrepressor
titrat
rna
marker
minicircl
promot
recogn
mammalian
express
system
play
signific
role
antigen
gene
express
cytomegaloviru
cmv
simian
viru
murin
leukemia
viru
promot
among
promin
promot
use
dna
vaccin
although
cmv
promot
activ
decreas
condit
use
conjunct
cytokin
treatment
combin
cmv
promot
intron
show
cmv
promot
effect
activ
gene
express
studi
also
combin
cmv
promot
compon
modifi
chicken
woodchuck
hepat
posttranscript
regulatori
element
wpre
creat
hybrid
promot
nonvir
promot
demonstr
compar
efficaci
cmv
promot
collagen
keratinocyt
promot
anoth
studi
indic
mhc
class
ii
promot
potent
gener
transgen
product
use
dna
vaccin
polyadenyl
sequenc
signific
effect
transgen
express
common
polyadenyl
sequenc
use
dna
vaccin
construct
rabbit
bovin
growth
hormon
polyadenyl
sequenc
locat
upstream
transgen
regul
transgen
translat
optim
regulatori
element
insert
sequenc
r
region
long
termin
repeat
human
tcell
leukemia
viru
type
cmv
enhancerpromot
markedli
increas
dna
vaccin
immunogen
mice
nonhuman
primat
dna
vaccin
deliveri
system
live
bacteri
vector
sever
benefit
bacteria
typic
use
deliveri
system
recombin
bacteria
genet
modifi
pathogen
compon
delet
attenu
bacteria
creat
nonvirul
organ
ensur
safeti
host
use
bacteria
carrier
vaccin
deliv
mucos
rout
includ
intranas
oral
intravagin
rout
mucos
rout
favor
noninvas
accept
administr
oral
rout
also
requir
special
skill
easier
manag
vaccin
mucos
rout
induc
mucos
system
immun
system
respons
bacteria
protect
dna
vaccin
harsh
environ
enzymat
reaction
gut
intranas
rout
also
thoroughli
develop
sinc
hinder
enzymat
reaction
withstand
high
acid
condit
gut
studi
show
vaccin
administ
intranas
rout
induc
better
immun
respons
compar
oral
rout
vaccin
mucos
surfac
first
locat
host
environ
contact
therefor
promin
defens
mechan
pathogen
mucos
rout
vaccin
deliveri
system
base
mucosaassoci
lymphoid
tissu
malt
found
variou
mucos
surfac
area
malt
lymphoid
tissu
nasopharynx
pharynx
salivari
gland
upper
respiratori
tract
known
nasalassoci
lymphoid
tissu
nalt
malt
also
found
broncho
epithelium
lower
respiratori
tract
balt
gastrointestin
tract
galt
genit
tract
malt
compos
epitheli
cell
identifi
follicleassoci
epithelium
microfold
cell
cell
act
first
mucos
barrier
system
initi
immun
respons
deliv
oral
rout
bacteria
dna
vaccin
enter
digest
system
intestin
surfac
bacteria
recogn
cell
peyer
patch
spread
lamina
propia
bacteria
specif
characterist
form
microbeassoci
molecular
pattern
mamp
recogn
particular
receptor
tolllik
receptor
nodlik
receptor
introduct
induc
nativ
immun
respons
increas
adapt
immun
respons
phagocyt
bacteria
shape
phagolysosom
trigger
cell
lysi
releas
plasmid
insid
bacteria
cell
compon
includ
plasmid
releas
engulf
dendrit
cell
dc
insid
dc
plasmid
enter
nucleu
special
compart
antigen
gene
express
host
express
system
express
antigen
present
class
mhc
activ
cell
antigen
also
express
extracellular
protein
present
class
ii
mhc
activ
antibodi
product
helper
cell
respons
figur
howev
precis
mechan
dna
transfer
live
bacteri
vector
yet
fulli
understood
mani
speci
suggest
mechan
base
bacteri
invas
properti
thu
invas
bacteria
salmonella
typhimurium
listeria
monocytogen
prefer
carrier
dna
vaccin
briefli
dna
vaccin
carrier
bacteria
divid
two
major
group
nonpathogen
bacteria
attenu
pathogen
bacteria
attenu
bacteria
studi
dna
vaccin
carrier
includ
salmonella
spp
yersinia
enterocolitica
shigella
spp
listeria
monocytogen
pathogen
bacteria
target
mucou
membran
infect
rout
result
suitabl
mucos
administr
howev
main
disadvantag
includ
likelihood
caus
infect
particularli
infant
immunocompromis
patient
therefor
nonpathogen
bacteria
lactic
acid
bacteria
lab
may
prefer
develop
dna
vaccin
carrier
comparison
properti
sever
strain
commonli
use
dna
vaccin
carrier
present
tabl
lab
excel
candid
manipul
dna
vaccin
carrier
lab
use
food
ferment
centuri
gener
recogn
safe
gra
organ
lab
also
resist
acid
condit
gastrointestin
gi
system
abl
deliv
vaccin
intestin
area
sever
lab
strain
famou
probiot
bacteria
lactobacillu
casei
lactobacillu
delbrueckii
lactobacillu
acidophilu
lactobacillu
plantarum
lactobacillu
fermentum
lactobacillu
reuteri
probiot
bacteria
reduc
lactos
intoler
symptom
diarrhea
flatul
appear
lactos
intoler
patient
consum
milk
probiot
bacteria
also
increas
immun
respons
toward
pathogen
inhibit
pathogen
colon
gi
tract
promot
mucos
immun
system
activ
plasma
cell
induc
secret
immunoglobulin
iga
migrat
cell
lactococcu
lacti
moststudi
lab
sinc
genom
easili
manipul
mani
genet
tool
engin
l
lacti
notabl
one
main
advantag
use
l
lacti
dna
vaccin
carrier
abil
pass
intestin
tract
without
colon
studi
confirm
l
lacti
abl
transfer
dna
plasmid
host
cell
studi
conduct
use
nativ
l
lacti
show
abil
deliv
dna
plasmid
mammalian
cell
coincub
led
express
secret
transgen
product
yagnik
et
al
show
l
lacti
capabl
transfer
dna
plasmid
cell
absenc
chemic
treatment
invas
protein
anoth
studi
demonstr
glycin
treatment
escal
dna
transfer
l
lacti
cell
abil
l
lacti
transfer
plasmid
mammalian
cell
vivo
confirm
deliveri
plasmid
l
lacti
murin
epitheli
membran
cell
protein
effect
express
mammalian
cell
express
system
sever
attempt
made
increas
efficaci
l
lacti
deliveri
insid
dna
host
cell
pvalac
new
plasmid
success
construct
demonstr
abil
deliv
interior
porcin
kidney
cell
line
major
advantag
pvalac
vector
small
size
kb
compar
previous
use
plasmid
plig
kb
smaller
plasmid
allow
clone
larger
dna
fragment
easier
transform
process
improv
intern
capac
l
lacti
express
listeria
monocytogen
invasin
internalin
inla
streptococcu
pyogen
fibronectionbind
protein
fnbpa
develop
internalin
mediat
intern
bind
interact
ecadherin
express
human
epitheli
endotheli
cell
analysi
show
strain
effect
deliv
dna
plasmid
cell
target
protein
express
insid
cell
anoth
studi
demonstr
l
lacti
express
internalin
abl
deliv
dna
dendrit
cell
either
directli
pass
epitheli
mono
layer
moreov
combin
invas
l
lacti
strain
express
pperdbi
report
plasmid
immunostimulatori
properti
success
increas
express
level
target
gene
cell
studi
demonstr
new
combin
increas
target
gene
express
threefold
compar
express
noninvas
l
lacti
strain
salmonella
spp
gramneg
bacterium
caus
salmonellosi
orofec
rout
dna
vaccin
carrier
enterica
serovar
typhimurium
typhimurium
wide
use
salmonella
spp
bacterium
suitabl
oral
administr
natur
infect
rout
howev
induc
mucos
system
immun
respons
activ
humor
cellular
immun
system
pathogen
bacteria
salmonella
spp
induc
immun
respons
lipopolysaccharid
lp
flagellin
content
surfac
recogn
pathogenassoci
molecular
pattern
pamp
flagellin
induc
immun
respons
bind
tolllik
receptor
wherea
lp
bind
bind
activ
nuclear
factorkappa
b
nfkb
mitogenactiv
protein
kinas
mapk
pathway
follow
releas
cytokin
enterica
virul
gene
encod
salmonella
pathogen
island
spi
two
main
spi
particip
host
cell
invas
intracellular
host
cell
surviv
respect
due
remark
pathogen
mutant
salmonella
develop
dna
vaccin
carrier
mutant
typhi
typhimurium
develop
vaccin
carrier
aroa
aroc
arod
mutat
mutat
salmonella
abl
produc
aromat
substanc
therefor
replic
insid
host
howev
bacteria
still
invad
host
intestin
surviv
long
enough
induc
immun
system
respons
mutant
type
also
establish
mutant
produc
guanin
adenin
base
caus
distress
cell
wall
product
dna
repair
system
virul
gene
regul
kong
et
al
success
construct
recombin
attenu
salmonella
mutant
strain
hyper
invas
phenotyp
invad
host
cell
escap
endosom
reduc
bacteria
apoptosi
consequ
dna
allow
effici
enter
nucleu
sever
manipul
studi
improv
abil
salmonella
spp
vaccin
carrier
includ
manipul
lipid
outer
membran
vesicl
engin
dualplasmid
system
describ
briefli
wang
et
al
typhimurium
mutant
demonstr
remark
candid
antiatherosclerosi
dna
vaccin
carrier
typhimurium
aroa
dam
oral
administr
contain
plasmid
gene
inhibit
atherosclerosi
decreas
aortic
lesion
size
atherosclerosi
model
mice
vascular
epitheli
growth
factor
receptor
encod
gene
mice
vaccin
activ
cell
inhibit
neoangiogenesi
involv
atherosclerosi
cellular
immun
respons
detect
decreas
express
endotheli
cell
approach
also
use
anoth
studi
conduct
hauer
et
al
manipul
typimurium
plasmid
encod
angiopoietin
receptor
endotheli
surfac
contribut
develop
atherosclerosi
oral
vaccin
atherosclerosi
model
mice
induc
cellular
immun
respons
decreas
atherosclerosi
lesion
stabil
plaqu
cellular
immun
respons
measur
decreas
number
endotheli
cell
express
vaccin
mice
similar
studi
use
dna
vaccin
encod
also
success
conduct
protein
express
leukocyt
endotheli
cell
involv
leukocyt
recruit
atherosclerosi
lesion
area
vaccin
consum
oral
typhimurium
aroa
carrier
vaccin
gener
cell
lyse
express
cell
fewer
leukocyt
detect
lesion
area
vaccin
also
decreas
lesion
format
carotid
arteri
liang
et
al
confirm
mutant
enterica
success
deliv
somatostatin
gene
mice
model
mutant
lack
antibiot
resist
gene
base
aspartatesemialdehyd
dehydrogenas
gene
select
marker
administ
bacteria
contain
dna
vaccin
effect
induc
mucos
system
immun
respons
safeti
vaccin
shown
neglig
integr
plasmid
gene
host
cellular
genom
bacteria
develop
dna
vaccin
carrier
includ
listeria
monocytogen
shigella
spp
yersinia
enterolica
l
monocytogen
gramposit
bacterium
invad
sever
cell
type
mucos
epitheli
cell
hepatocyt
macrophag
dc
epitheli
cell
bloodbrain
barrier
bacteria
invad
divid
insid
mammalian
cell
consequ
induc
high
immun
respons
l
monocytogen
spread
cell
make
effect
dna
vaccin
carrier
cancer
given
abil
infect
intestin
epithelium
l
monocytogen
becom
attract
candid
oral
vaccin
deliveri
disadvantag
organ
pathogen
lead
cholecyst
human
mice
infect
l
monocytogen
show
bacteri
colon
gall
bladder
mutant
variant
develop
mutat
gene
encod
biotin
metabol
ligas
lipoat
put
protein
mutant
variant
confirm
induc
immun
respons
replic
gall
bladder
anoth
studi
use
mutant
l
monocytogen
show
bacterium
ingest
oral
deliv
dna
vaccin
contain
ovalbumin
encod
gene
increas
antibodi
titer
vaccin
mice
serum
demonstr
express
antigen
induc
immun
respons
differ
studi
indic
attenu
recombin
l
monocytogen
plasmid
encod
mycobacterium
tuberculosi
antigen
capabl
induc
robust
cellular
immun
respons
mice
convers
studi
conduct
loeffler
et
al
reveal
l
monocytogen
induc
better
immun
respons
deliv
recombin
antigen
protein
plasmid
dna
antigen
express
l
monocytogen
significantli
increas
cell
respons
wherea
dna
vaccin
carri
l
monocytogen
fail
induc
specif
cell
respons
shigella
spp
use
dna
vaccin
carrier
due
abil
retain
cytoplasm
evad
endosom
thu
effect
deliv
dna
nucleu
shigella
also
natur
abil
target
lymphoid
tissu
trigger
optim
mucos
system
immun
system
studi
show
efficaci
dna
vaccin
carri
mutant
flexeneri
attenu
human
immunodefici
viru
hiv
infect
murin
model
singl
dose
flexeneri
vaccin
given
intranas
induc
robust
cell
respons
similar
vivo
studi
demonstr
flexeneri
mutant
success
deliv
dna
vaccin
encod
hiv
gag
gene
dna
vaccin
intranas
deliv
recombin
bacteria
induc
cellular
immun
respons
compar
nake
dna
vaccin
given
intramuscularli
enterocolitica
chosen
dna
vaccin
carrier
surviv
host
tissu
sever
day
period
dna
vaccin
replic
accord
enterocolitica
prolifer
increas
amount
dna
vaccin
previou
studi
enterocolitica
proven
deliv
dna
vaccin
encod
brucella
antigen
bacterioferritin
bfr
dna
vaccin
induc
antigenspecif
antibodi
respons
vaccin
mice
show
resist
brucella
infect
dna
vaccin
face
challeng
term
effect
deliveri
system
effect
target
immun
system
live
vector
bacteria
new
promis
agent
vaccin
deliveri
bacteria
uniqu
natur
characterist
promot
immun
respons
howev
main
concern
bacteria
vaccin
carrier
patient
safeti
although
attenu
recombin
strain
develop
nonpathogen
bacteria
lab
consid
suitabl
dna
vaccin
carrier
